Timothy Kieffer
Chief Tech/Sci/R&D Officer at FRACTYL HEALTH, INC.
Net worth: - $ as of 30/04/2024
Profile
Timothy Kieffer is currently the Chief Scientific Officer at Fractyl Health, Inc. He previously held the position of Chief Scientific Officer at ViaCyte, Inc. from 2021 to 2022.
Prior to his industry roles, he worked as a Professor at the University of British Columbia.
Dr. Kieffer obtained a doctorate degree from the University of British Columbia.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
FRACTYL HEALTH, INC.
-.--% | 15/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Timothy Kieffer active positions
Companies | Position | Start |
---|---|---|
FRACTYL HEALTH, INC. | Chief Tech/Sci/R&D Officer | 01/09/2023 |
Former positions of Timothy Kieffer
Companies | Position | End |
---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/10/2022 |
University of British Columbia | Corporate Officer/Principal | - |
Training of Timothy Kieffer
University of British Columbia | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
FRACTYL HEALTH, INC. | Health Technology |
Private companies | 1 |
---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Timothy Kieffer